OTC: IPSEF - Ipsen S.A.

Altı ay boyunca karlılık: +2.5%
Temettü getirisi: +0.96%
Sektör: Healthcare

Promosyon programı Ipsen S.A.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Ipsen S.A.

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Dysport for motor muscular disorders and medical aesthetics; Decapeptyl for the treatment of advanced metastatic prostate cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; and Tazverik to treat third-line follicular lymphoma.

daha fazla ayrıntı
The company also provides NutropinAq for growth failure in children due to growth hormone (GH) deficiency, turner syndrome or chronic renal insufficiency, and GH deficiency in adults; and Increlex for growth failure in children and adolescents. In addition, it offers Xermelo for the treatment of carcinoid syndrome; and Cometriq to treat medullary thyroid cancer. Ipsen S.A. has agreements with Debiopharm; Exelixis; Galderma; Blueprint Medicines; TerSera Therapeutics; Rhythm Pharmaceuticals; Teijin; Schwabe; BAKX Therapeutics Inc.; and Exicure. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета eur
Див.доход ао 0.9639
Дивиденд ао 1.16
Сайт https://www.ipsen.com
Цена ао 120.55
Günlük fiyat değişimi: 0% (120.55)
Haftalık fiyat değişimi: 0% (120.55)
Aylık fiyat değişimi: 0% (120.55)
3 ayda fiyat değişimi: -3.84% (125.37)
Altı ayda fiyat değişimi: +2.5% (117.61)
Yıllık fiyat değişimi: +2.51% (117.6)
Yılbaşından bu yana fiyat değişimi: -3.84% (125.37)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 2.63 6
P/BV 2.15 7
P/E 12.77 8
EV/EBITDA 8.63 8
Toplam: 7.88

Yeterlik

İsim Anlam Seviye
ROA, % 10.19 4
ROE, % 16.85 5
Toplam: 5

Temettüler

İsim Anlam Seviye
Div yield, % 0.9639 2.4
DSI 0.8571 8.57
Toplam: 2.86

Görev

İsim Anlam Seviye
Debt/EBITDA 0.4137 10
Toplam: 9.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 22.79 4
karlılık Ebitda, % 4.08 1
karlılık EPS, % -1246.72 0
Toplam: 2.8
Daha fazla ayrıntı



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. David Loew MD, CEO & Director 2.41M 1967 (58 yıllar)
Mr. Aymeric Le Chatelier Executive VP & CFO 792.51k 1969 (56 yıllar)
Dr. Aidan Murphy Ph.D. Executive VP and Head of Technical Operations N/A 1966 (59 yıllar)
Mr. Craig Marks Vice-President of Investor Relations N/A
Mr. Francois Garnier Executive VP of Legal Affairs, General Counsel & Chief Business Ethics Officer N/A 1962 (63 yıl)
Mr. Regis Mulot Executive VP & Chief Human Resources Officer N/A 1966 (59 yıllar)
Ms. Dominique Bery Head of Nordics & Baltics N/A 1971 (54 yıl)
Mr. Bartosz Bednarz D.D.S. Executive VP and Head of Global Product & Portfolio Strategy N/A
Mr. Philippe Lopes-Fernandes CBO Executive VP & Chief Business Officer N/A
Dr. James Levine M.D., Ph.D. President of Fondation Ipsen

Adres: France, Boulogne-Billancourt, 65 quai Georges Gorse - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.ipsen.com